In this study, we investigated the roles and mechanisms of action of CIP2A in metabolic reprogramming, and found that CIP2A promoted oxidative metabolism in NSCLC cells through induction of PKM2 oligomerization, with S287 as key amino acid in determining dimer-tetramer switching. Here, PKM is linked to non-small cell lung carcinoma.